☆ 4.7 Article

Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study

VACCINES (2022)

Related references

Note: Only part of the references are listed.

Article Immunology

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Chanu Rhee et al.

Summary: SARS-CoV-2 is most contagious around symptom onset, with infectivity rapidly decreasing to near-zero afterwards; mild-moderately ill patients can safely discontinue isolation after about 10 days, while severely-critically ill and immunocompromised patients may need 15 days. The longest duration associated with replication-competent virus is 20 days.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy

Valentina Orlando et al.

Summary: This study identified conditions and diseases that make people more vulnerable to SARS-CoV-2 infection, supporting decision-makers in identifying high-risk individuals and adopting preventive measures to minimize the spread of further epidemic waves.

PLOS ONE (2021)

Add to Collection

Review Infectious Diseases

What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2

Susanne H. Hodgson et al.

Summary: The development of a vaccine for the novel coronavirus is crucial to prevent the spread of the pandemic and reduce disease mortality. The efficacy endpoint is protection against severe disease and death, but evaluating this in phase 3 clinical trials poses challenges.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Virology

Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism

Alessandro Perrella et al.

Summary: Researchers analyzed the infection rate of COVID-19 patients before and after treatment with hydroxychloroquine, considering its immunomodulatory and antiviral properties.

VIRUSES-BASEL (2021)

Add to Collection

Review Immunology

COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

Malik Sallam

Summary: COVID-19 vaccine acceptance rates are generally high worldwide, but low rates are reported in the Middle East, Russia, Africa, and certain European countries. This could pose a significant challenge in global efforts to control the pandemic. More studies are recommended to address COVID-19 vaccine hesitancy in different regions.

VACCINES (2021)

Add to Collection

Article Environmental Sciences

Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy

Kevin Bliek-Bueno et al.

Summary: This study identified baseline medications that are associated with increased mortality risk in COVID-19 patients in Spain and Italy. Treatments for chronic cardiovascular diseases, inflammation, and thrombosis risk-increasing diseases may serve as timely indicators of mortality risk after infection.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Article Multidisciplinary Sciences

Drug-utilisation profiles and COVID-19

Valentina Orlando et al.

Summary: A study in Southern Italy investigated drug utilization in COVID-19 patients, revealing higher prevalence of certain drug categories related to comorbidities. However, there was no significant difference in the use of drugs affecting the renin-angiotensin system between COVID-19 and non-COVID-19 patients. Further case-control studies are needed to understand the effects of medications and comorbidities on susceptibility and mortality from COVID-19.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 in Urine May Predict a Severe Evolution of COVID-19

Alessandro Perrella et al.

Summary: The presence of SARS-CoV-2 in urine is associated with disease severity in COVID-19 patients, leading to a higher mortality rate.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Immunology

Postvaccination COVID-19 among Healthcare Workers, Israel

Sharon Amit et al.

Summary: Symptoms of COVID-19 can be mistaken for vaccine-related side effects, highlighting the importance of promptly testing for COVID-19 after vaccination. In a study of healthcare workers in Israel, a small percentage developed COVID-19 within 10 days of vaccination, emphasizing the need for vigilance in monitoring post-vaccination symptoms.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Letter Immunology

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy

Andrea Calcagno et al.

Summary: In a study involving 5,444 active healthcare workers in Italy, the seroprevalence of SARS-CoV-2 spike protein subunits S1/S2 antibodies was found to be 6.9%, with higher rates among those who had contact with patients. Out of 213 previously infected participants, 37 did not show seroconversion.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Current advances in the development of SARS-CoV-2 vaccines

Annoor Awadasseid et al.

Summary: COVID-19 caused by SARS-CoV-2 has become a global pandemic, with China being at the forefront of vaccine development. The last inactivated vaccine international clinical trial has been launched in the UAE, showing promising progress in creating efficacious and safe vaccines against SARS-CoV-2.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Current knowledge of COVID-19 and infection prevention and control strategies in healthcare settings: A global analysis

M. Saiful Islam et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Vaccine hesitancy: the next challenge in the fight against COVID-19

Amiel A. Dror et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Feng-Cai Zhu et al.

LANCET (2020)

Add to Collection

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

Add to Collection

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Immunology

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

Omna Sharma et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Immunology

SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel Detroit Metropolitan Area, Michigan, USA, May-June 2020

Lara J. Akinbami et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection

Article Immunology

High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020

Matt Feaster et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Are you more concerned about or relieved by medicines? An explorative randomized study of the impact of telephone counseling by pharmacists on patients' beliefs regarding medicines and blood pressure control

Daniela Scala et al.

PATIENT EDUCATION AND COUNSELING (2018)

Add to Collection

Review Medicine, General & Internal

Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea

Myoung-don Oh et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2018)

Add to Collection

© Peeref 2019-2024. All rights reserved.